Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
NCT01720069
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
VR506
Sponsor
Vectura Limited